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Background: There have been several reports concerning the survival time after symptom onset in patients with
amyotrophic lateral sclerosis (ALS). However, little is known about how the choice of physician (i.e., general
practitioner, neurologist, etc.) may affect the time it takes for a diagnosis of ALS to be made.
Methods: We conducted a retrospective study, covering a 20-year period, comparing the type of physician first
consulted by an ALS patient at the time of initial symptoms and the amount of time that elapsed to the final
diagnosis of ALS. A total of 202 patients were diagnosed and stratified according to the onset of ALS symptoms
(bulbar onset [BO] and limb onset [LO]). We noted the type of physician first seen by the patient. The diagnostic
interval was calculated as the time between onset of symptoms and the final diagnosis of ALS.
Results: A total of 202 ALS patients were examined. Clinical BO and LO was observed in 78 (36.6%) and in 124
(61.4%) of these patients, respectively. The type of physician examining these patients at the first symptoms of
disease was as follows (BO and LO): neurologist (38.5% and 25.8%), general practitioner (14.1% and 35.5%),
orthopedist (12.8% and 35.5%), otolaryngologist (15.4% and 0%), and neurosurgeon (14.1% and 3.2%). Mean
diagnostic interval (standard deviation) for patients with either set of symptoms was 13.1 (6.5) months; the
diagnostic interval of patients with BO and LO was 9.2 (4.5) and 15.2 (7.7) months, respectively. ALS diagnosis in LO
patients was delayed by more than 10 months when the patient first consulted an orthopedist rather than a
neurologist.
Conclusion: More than 50% of the ALS patients included in this study did not visit a neurologist at the first
symptoms of disease onset. The diagnosis of ALS was prolonged in LO patients visiting an orthopedist. We
speculate that this increase in the diagnostic interval in LO patients visiting an orthopedist was due to a lack of
bulbar symptoms in the early stages of this disease.
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Amyotrophic lateral sclerosis (ALS) is a progressive
neurodegenerative disorder primarily involving motor
neurons in the cerebral cortex, brainstem, and spinal
cord. The variability in clinical findings early in the
course of ALS and the lack of any diagnostic biological
marker make absolute diagnosis difficult. The El Escorial
criteria (EE) for diagnosing ALS [1] have been widely* Correspondence: osamukano@aol.com
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reproduction in any medium, provided the oraccepted and were revised (REE) in 2000 to increase
their sensitivity [2]. On the therapeutic front, riluzole
has been shown to increase survival in controlled trials
[3], although the effect is minimal. Percutaneous
gastrostomy (PEG) and noninvasive ventilation (NIV)
have also been shown to prolong survival and improve
the quality of life [4-6]. However, this improvement is
still controversial due to questions about the natural
history of ALS. In a recent epidemiologic study, recent
ALS patients had significantly prolonged survival and
slower disease progression compared to patients from
older studies [7]. Moreover, a significant increase ind. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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observed over a 28-year period [8]. In contrast, no
significant change in survival was shown in patients
treated more recently, despite the introduction of sup-
portive measures (NIV, PEG, and riluzole) [9]. TheseFigure 1 Diagnostic pathway from symptom onset to final diagnosis
otolaryngologist, NS: neurosurgeon.studies have investigated the survival of ALS patients;
however, little is known about the relationship between
the time the patient first seeks medical attention for the
initial symptoms of the disease and its influence on the
time to actual diagnosis of ALS [10,11]. We conducted aof ALS. GP: general practitioner, ORTH: orthopedist, ENT:
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time it took to attain a final diagnosis of ALS depending
on the specialty of the first physician each patient saw
and the type of onset symptoms (bulbar onset [BO] and
limb [LO] onset).Methods
We reviewed the hospital records of all ALS patients
who fulfilled the REE (definite, probable, or probable-
laboratory-supported) [2] at Toho University Omori
Medical Center, Tokyo, Japan from January 1, 1990 to
July 31, 2011. The diagnosis of ALS was made by con-
sulting neurologists with extensive experience (OK, KI,
and YI). The patients were stratified according to onset
symptoms of ALS, either BO or LO. The type of phys-
ician first visited was noted, and the diagnostic interval
was calculated as the time between onset of symptoms
and the final diagnosis of ALS (Figure 1). Statistical
analysis was carried out with the Mann–Whitney U test,
and P < 0.01 was considered statistically significant. The
present study was approved by the Ethical Committee
of Toho University Omori Medical Center (Reference
no. 23–10).Results
Demographics
A total of 202 patients fulfilled the REE. BO and LO onset
symptoms were observed in 78 (36.6%) and 124 (61.4%)
patients, respectively. The mean age of symptom onset was
60.8 years (standard deviation [SD] = 11.3; range 26–83);
the male to female ratio for all symptoms was 1.6:1, with a
breakdown of 1.1:1 in the BO group and 2.1:1 in the LO
group. These results are summarized in Table 1.Table 1 Demographics, diagnostic interval, and diagnostic pa
T
Demographics
No. of patients (%) 2
Gender ratio F:M 1
Mean age of onset in years (SD) 6
Diagnostic Interval
Average number of months from symptom onset (SD) 1
Diagnostic Pathway
Neurologist, n (%) 6
General Practitioner, n (%) 5
Orthopedist, n (%) 5
Otolaryngologist, n (%) 1
Neurosurgeon, n (%) 1
Others, n (%) 4Diagnostic interval and initial screening physician
The diagnostic interval (SD in parentheses) from
symptom onset to diagnosis was 13.1 (6.5) months
irrespective of the particular symptoms. The symptom-
dependent diagnostic interval was 9.2 (4.5) months in
the BO group and 15.2 (7.7) months in the LO group.
The patient ratio (BO:LO) was 38.5%:25.8% for
patients who visited a neurologist at the first symptoms
of disease, 14.1%:35.5% for those who visited a general
practitioner (GP), 12.8%:35.5% for those who visited an
orthopedist (ORTH), 15.4%:0% for those who visited
an otolaryngologist (ENT), 14.1%:3.2% for those who
visited a neurosurgeon (NS), and 5.1%:0% for those
who visited all other practitioners. More than 50% of
the ALS patients examined in this study did not visit a
neurologist at the first symptoms of disease (Table 1).
The diagnostic pathway from the onset of symptoms
to final diagnosis of ALS is summarized in Figure 1.
Fourteen ALS patients visited 2 clinics before finally
visiting a neurologist in the BO group. On the other
hand, 24 patients visited 2 clinics and 5 patients visited
3 clinics in the LO group.Diagnostic interval for patients with BO and LO
The diagnostic interval from symptom onset to final
diagnosis is summarized in Figure 2. There were no
statistical differences among BO patients. However, the
diagnosis of LO was delayed by more than 10 months
in patients who saw an ORTH first as compared to
those whose initial visit was with a neurologist (P <
0.01). There were no differences between patients who
visited a neurologist and those who visited any of the
other physicians investigated.thway of ALS patients
otal Bulbar onset Limb onset
02 78 (36.6) 124 (61.4)
:1.6 1:1.1 1:2.1
0.8 (11.3) 58.1 (11.0) 63.2 (10.6)
3.1 (6.5) 9.2 (4.5) 15.2 (7.7)
2 (30.7) 30 (38.5) 32 (25.8)
5 (27.2) 11 (14.1) 44 (35.5)
4 (26.7) 10 (12.8) 44 (35.5)
2 (5.9) 12 (15.4) 0
5 (7.4) 11 (14.1) 4 (3.2)
(2.0) 4 (5.1) 0
Figure 2 Diagnostic interval of ALS patients. The length of time
taken for a final diagnosis of ALS from symptom onset. LO patients
visiting an ORTH showed a more than 10-month delay in ALS
diagnosis compared to those who visited a neurologist after
presentation of initial symptoms. *P < 0.01 vs. Neurologist, LO.
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in LO patients
We analyzed the characteristic differences between
patients who were referred to a neurologist directly from
an ORTH and those who were referred from an ORTH
to other clinics before finally visiting a neurologist
(Table 2). Three patients who were referred directly to a
neurologist received spinal surgery. However, there were
no differences in mean age, spinal spondylosis, or
diagnostic interval between these 2 groups.
Discussion
The medical system for patients varies from country to
country. In Japan, it is recommended that patients have
their own primary care doctor; however, they can visit any
clinic first freely and without a referral. Once they visit a
clinic, the physician makes a referral to the specialist if
needed. Therefore, it is difficult to make a country-to-
country comparison of the duration between onset of
symptoms and diagnosis of ALS.Table 2 Direct and indirect referral from an ORTH to a neurol
ORT
Demographics
No. of patients (%) 34 (
Gender ratio F:M 1:2.4
Mean age of onset in years (SD) 63.1
Spinal spondylosis, n (%) 20 (
Spinal surgery, n (%)* 3 (8
Diagnostic Interval
Average number of months from symptom onset (SD) 21.9
*Diagnosed by a neuroradiologist.The diagnosis of ALS is achieved by examination and
a series of investigations designed to exclude other
clinical syndromes. One of the most valuable aspects to
an early ALS diagnosis is the ability to provide the best
quality of life for the patient and their caregivers. In
addition, it is likely that potential treatment options in
the future will have greater effects if administered at the
first symptoms of the disease.
Several studies investigating survival [7-9,12-16],
diagnostic interval [14], and initial physician contact
[10,11] in ALS have been reported. We evaluated only
the diagnostic interval in order to exclude the influ-
ence of supportive measures and focus on the time
lapse that can be induced when diagnoses are made by
physicians of various backgrounds. The demographic
data of the population of this study was similar to that
in previous reports with respect to gender, site of
initial symptoms, and the age of onset [13]. We also
found that ENT specialists tend to see more BO
patients, and ORTH specialists tend to see more LO
patients. These findings have also been observed in
different countries [10,11]. Diagnostic interval tends to
be longer in LO patients compared to BO patients.
Our results show that LO patients who visit an ORTH
first have a longer diagnostic interval compared to
those who visit a neurologist first. Furthermore, no dif-
ference could be seen between LO patients who visited
a neurologist first and those who visited any of the
other physicians investigated. We also compared the
characteristic differences between LO patients who
were referred to a neurologist directly and those who
were referred from an ORTH to other clinics before
finally visiting a neurologist. Three patients directly
referred to a neurologist received spinal surgery, but
there were no differences between these 2 groups in
mean age, spinal spondylosis, or diagnostic interval. A
high incidence of spondylosis is reported in patients at
the mean age of ALS onset, and about 4% of ALS
patients undergo decompressive spinal surgery after
the onset of retrospectively recognized symptoms ofogist in LO patients
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recognized in the evaluation of weakness, even in the
presence of radiographic evidence of spinal spondylosis.
Turner et al. [11] reported the diagnostic pathway and
prognosis in BO patients. About 50% of BO patients
visited other specialists before visiting a neurologist, but
this did not influence diagnostic latency or overall
survival. To our knowledge, our study is the first report
to describe the relationship between diagnostic pathway,
the specialty of the physician initially assessing the ALS
patient, and the diagnostic interval in LO patients. We
speculate that the increase in diagnostic interval
observed in LO patients visiting an ORTH was because
of a lack of bulbar symptoms in the early stages of this
disease. In addition, ORTH specialists may pay attention
to spondylotic myelopathy and radiculopathy, which
often coexist in older persons.Conclusion
In this study, we have shown that more than 50% of
patients with ALS were referred to an inappropriate
clinic prior to final diagnosis. When investigating LO
ALS patients, those who chose to consult a neurologist
first after the onset of symptoms were diagnosed more
than 10 months ahead of LO patients who chose to
consult an ORTH first. Therefore, we suggest a greater
understanding and awareness of ALS through the
increased education of non-neurological physicians.
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